T
Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
NASDAQ:TLIS
Price:
9.15 USD
0.55%
Market Closed
Updated:
May 5, 2024
Talis Biomedical Corp
Cash from Financing Activities
|
Talis Biomedical Corp
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
Cash from Financing Activities
$410k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Talis Biomedical Corp's Cash from Financing Activities?
Cash from Financing Activities
410k
USD
410k
USD
Based on the financial report for Dec 31, 2022, Talis Biomedical Corp's Cash from Financing Activities amounts to 410k USD.
What is Talis Biomedical Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-78%
-78%
Over the last year, the Cash from Financing Activities growth was -100%. The average annual Cash from Financing Activities growth rates for Talis Biomedical Corp have been -78% over the past three years .
You don't have any saved screeners yet
